Moderna Inc (NAS:MRNA)
$ 43.39 1.34 (3.19%) Market Cap: 16.70 Bil Enterprise Value: 10.67 Bil PE Ratio: 0 PB Ratio: 1.40 GF Score: 66/100

Moderna Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 02:00PM GMT
Release Date Price: $131.3 (-6.43%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Good morning, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Really pleased to have Moderna with us. Quickly before we get started, I need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.

So really pleased to have Stephen Hoge, who is the President of Moderna with us.

Questions & Answers

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Stephen, I thought a good place to start off is, before we go into details about the many programs that you have ongoing, everybody obviously knows the company because of COVID. And as I think about the stock, right, there's a decent amount of debate still on what the COVID tail looks like. But I think when you think about the company,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot